表紙:ケモインフォマティクス市場の2030年までの予測:製品別、用途別、エンドユーザー別、地域別の世界分析
市場調査レポート
商品コード
1383333

ケモインフォマティクス市場の2030年までの予測:製品別、用途別、エンドユーザー別、地域別の世界分析

Cheminformatics Market Forecasts to 2030 - Global Analysis By Product (Services, Software and Other Products), Application, End User and By Geography

出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 200+ Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.08円
ケモインフォマティクス市場の2030年までの予測:製品別、用途別、エンドユーザー別、地域別の世界分析
出版日: 2023年11月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Stratistics MRCによると、世界のケモインフォマティクス市場は2023年に34億米ドルを占め、予測期間中のCAGRは17.5%で成長し、2030年には105億米ドルに達する見込みです。

ケモインフォマティクスは、化学に関連する様々な問題に対するコンピュータと情報のアプローチの統合です。ケモインフォマティクスは、医薬品リードの最適化の分野でより良い意思決定を迅速に行うために、データを知識に、知識を情報に変換することを目的として、様々な情報資源を融合させるものです。製薬会社は新薬を探す際にこれらの手法を採用しています。これらの技術は、化学および関連分野の他のさまざまな状況でも適用できます。

2021年4月にFrontiers in Chemistryが発表した報告書によると、バーチャル・スクリーニング戦略は新しい生物活性分子の発見に革新をもたらしました。

医薬品開発と発見の増加

バイオテクノロジーや製薬の分野では、常に最先端の医薬品を開発し、市場開拓しようと努力しています。ケモインフォマティクスのソフトウェアと技術は、医薬品開発プロセスを改善するため、この努力に不可欠です。これらのツールの支援により、研究者は大規模なデータセットを迅速に調査し、分子間相互作用をモデル化し、可能性のある薬剤候補の特性を予測することができ、試行錯誤の方法に通常伴う時間と費用を大幅に削減することができます。さらに、ケモインフォマティクスは、化学者が興味深い医薬品候補を発見し、化合物の構造と活性の関連を理解し、これらの分子の特性を改善するのに役立ちます。その結果、ケモインフォマティクスの市場は急速に拡大しており、企業はこれらの技術を利用して創薬を加速し、最終的には様々な健康問題に対処するための新薬や治療法のリリースにつなげようとしています。

高額な初期費用

ケモインフォマティクスシステムを導入し、必要なソフトウエア、ハードウエア、知識を得るには、特に新興企業、学術機関、経営資源が限られている小規模な研究機関にとっては、高額な費用がかかる場合があります。多くの潜在的ユーザーにとって、高度なケモインフォマティクスソフトウェアのライセンシング、強力な計算資源の購入、これらのツールを効果的に利用するための従業員のトレーニングにかかる費用は、参入障壁となる可能性があります。また、メンテナンス、アップデート、サポートにかかる継続的なコストも、経済的負担に拍車をかけています。

毒性ケモインフォマティクス

化学物質や医薬品の安全性と有効性を確保する上で重要な役割を果たすため、毒性ケモインフォマティクスはケモインフォマティクス市場の主要な促進要因となっています。ケモインフォマティクス技術は、厳格な安全性評価と規制遵守に対する需要の高まりにより、様々な化学物質の潜在的な毒性学的影響を予測・評価するために極めて重要です。さらに、これらの技術を利用することで、科学者は化学物質が生物学的システムとどのように相互作用するかをモデル化し、シミュレーションすることができます。この技術は、公衆衛生を守り、時間と資源を大幅に節約する上で重要な役割を果たします。

データのセキュリティとプライバシーの問題

この分野では、見込みのある医薬品化合物、分子構造、研究結果の詳細を含む、大量の機密性の高い化学的・生物学的データが扱われます。特に競争の激しい化学・製薬業界では、このデータを不正アクセス、違反、盗難から守ることが最優先事項です。しかし、法的規制や倫理的配慮、研究者が厳格なデータ保護法に従い、プライバシーや知的財産の問題に対処する必要性から、こうした困難はさらに深刻化しています。データ漏洩や不適切な扱いは、法的な影響や風評被害など深刻な影響を及ぼす可能性があります。

COVID-19の影響:

COVID-19の大流行は、ケモインフォマティクスの市場にさまざまな影響を与えました。その一方で、迅速なウイルス治療とワクチン接種の必要性が、医薬品開発におけるケモインフォマティクス技術の使用を後押ししました。これらの技術は、薬物開発プロセスを加速させ、ウイルスの分子構造や治療薬候補分子との相互作用を調べるために研究者によって使用されました。その結果、化学製品やサービスのニーズが高まっています。しかし、パンデミックはケモインフォマティクス分野に困難をもたらしました。サプライチェーンの混乱、研究所の閉鎖、研究目的の変更などにより、業界の一般的な運営に影響が出ました。

予測期間中、バーチャルスクリーニング分野が最大になる見込み

予測期間中、バーチャル・スクリーニングセグメントが最大のシェアを占める。バーチャル・スクリーニングは、ケモインフォマティクス分野のソフトウェアやツールを利用して、治療可能な分子とタンパク質や酵素などの特定の生物学的標的との相互作用を予測・検討するコンピューティング手法です。これにより、科学者は膨大な化合物ライブラリーを仮想的に評価することができ、追加的な実験試験を行う治療薬候補の数を減らすことができます。研究室で製造・分析しなければならない化合物の数を最小限に抑えることで、この方法は、少ない資本で創薬パイプラインを大幅にスピードアップします。

予測期間中にCAGRが最も高くなると予想されるのはソフトウェア分野です。

多くの分野の研究者、化学者、科学者の要求を満たすために開発された多種多様な専門的ソフトウェアプログラムやツールにより、ソフトウェア分野は予測期間を通じて最も高いCAGRを示すと予想されます。さらに、これらのソフトウェア・プログラムは、化学的および生物学的データの処理と評価、分子モデリングの支援、化学的特性の予測、新薬の創製のスピードアップのために作られています。ケモインフォマティクスソフトウェアには、仮想スクリーニング、データの可視化と分析、化学構造データベース、分子モデリングのためのツールが含まれます。

最大のシェアを占める地域:

バイオテクノロジー産業における資金調達の増加により、予測期間中、北米が市場の大半を占めました。この地域では、創薬、新しいプラットフォームのリリースと承認が加速しており、多数の重要な企業が存在しています。例えば、Dotmatics社は2022年7月に米国で低分子創薬サービスを発表しました。これは科学研究開発のための統合プラットフォームで、データ管理機能の拡大とワークフローがすでに設定されています。低分子創薬ソリューションは、業務の非効率性を最小化し、研究チームの効率を高め、データ洞察と意思決定への転換を促進します。

CAGRが最も高い地域:

アジア太平洋は、製造コストや労働コストが低く、産業環境が整備されているため、予測期間中に有利な成長が見込まれます。インド、中国、シンガポールなど、アジア太平洋の新興経済諸国は、大手多国籍企業の研究誘致に成功しています。さらに、アジア太平洋の急速に発展している国々における研究活動の増加率が、成長をさらに後押しすると予想されます。

無料カスタマイズサービス:

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます:

  • 企業プロファイル
    • 追加市場参入企業の包括的プロファイリング(3社まで)
    • 主要企業のSWOT分析(3社まで)
  • 地域セグメンテーション
    • 顧客の関心に応じた主要国の市場推定・予測・CAGR(注:フィージビリティチェックによる)
  • 競合ベンチマーキング
    • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

  • 概要
  • ステークホルダー
  • 調査範囲
  • 調査手法
    • データ鉱業
    • データ分析
    • データ検証
    • 調査アプローチ
  • 調査ソース
    • 1次調査ソース
    • 2次調査ソース
    • 前提条件

第3章 市場動向分析

  • イントロダクション
  • 促進要因
  • 抑制要因
  • 機会
  • 脅威
  • 製品分析
  • 用途分析
  • エンドユーザー分析
  • 新興市場
  • 新型コロナウイルス感染症(COVID-19)の影響

第4章 ポーターのファイブフォース分析

  • 供給企業の交渉力
  • 買い手の交渉力
  • 代替品の脅威
  • 新規参入業者の脅威
  • 競争企業間の敵対関係

第5章 世界のケモインフォマティクス市場:製品別

  • イントロダクション
  • サービス
  • ソフトウェア
  • その他の製品

第6章 世界のケモインフォマティクス市場:用途別

  • イントロダクション
  • 化学分析
    • ケモメトリクス
    • 化学データベース
    • 分子モデリング
    • その他の化学分析
  • バーチャル上映会
  • 創薬と検証
  • その他の用途

第7章 世界のケモインフォマティクス市場:エンドユーザー別

  • イントロダクション
  • 学術研究機関
  • バイオテクノロジー企業
  • 受託研究機関
  • 製薬会社
  • 規制コンプライアンス
  • その他のエンドユーザー

第8章 世界のケモインフォマティクス市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他の欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他のアジア太平洋
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他の南米
  • 中東およびアフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他の中東およびアフリカ

第9章 主な発展

  • 契約、パートナーシップ、コラボレーション、合弁事業
  • 買収と合併
  • 新製品の発売
  • 事業拡大
  • その他の主要戦略

第10章 企業プロファイル

  • Advanced Chemistry Development, Inc.
  • Advent Informatics Pvt. Ltd.
  • Agilent Technologies, Inc.
  • Altoris
  • Bio-Rad Laboratories, Inc
  • BioSolveIT GmbH
  • Cambridgesoft Corp
  • Certara, Inc.
  • ChemAxon Inc
  • Collaborative Drug Discovery Inc.
  • Dassault Systems SE
  • Eidogen-Sertanty, Inc.
  • Golden Helix, Inc.
  • Kode Chemoinformatics
  • Modgraph Consultants Ltd.
  • Molecular Discovery Ltd
  • Molinspiration Cheminformatics
  • Molsoft L.L.C
  • RTI International
  • Schrodinger, Inc.
  • Scilligence Corporation
図表

List of Tables

  • Table 1 Global Cheminformatics Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Cheminformatics Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Cheminformatics Market Outlook, By Services (2021-2030) ($MN)
  • Table 4 Global Cheminformatics Market Outlook, By Software (2021-2030) ($MN)
  • Table 5 Global Cheminformatics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 6 Global Cheminformatics Market Outlook, By Application (2021-2030) ($MN)
  • Table 7 Global Cheminformatics Market Outlook, By Chemical Analysis (2021-2030) ($MN)
  • Table 8 Global Cheminformatics Market Outlook, By Chemometrics (2021-2030) ($MN)
  • Table 9 Global Cheminformatics Market Outlook, By Chemical Databases (2021-2030) ($MN)
  • Table 10 Global Cheminformatics Market Outlook, By Molecular Modelling (2021-2030) ($MN)
  • Table 11 Global Cheminformatics Market Outlook, By Other Chemical Analysis (2021-2030) ($MN)
  • Table 12 Global Cheminformatics Market Outlook, By Virtual Screening (2021-2030) ($MN)
  • Table 13 Global Cheminformatics Market Outlook, By Drug Discovery and Validation (2021-2030) ($MN)
  • Table 14 Global Cheminformatics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 15 Global Cheminformatics Market Outlook, By End User (2021-2030) ($MN)
  • Table 16 Global Cheminformatics Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
  • Table 17 Global Cheminformatics Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
  • Table 18 Global Cheminformatics Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 19 Global Cheminformatics Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
  • Table 20 Global Cheminformatics Market Outlook, By Regulatory Compliance (2021-2030) ($MN)
  • Table 21 Global Cheminformatics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 22 North America Cheminformatics Market Outlook, By Country (2021-2030) ($MN)
  • Table 23 North America Cheminformatics Market Outlook, By Product (2021-2030) ($MN)
  • Table 24 North America Cheminformatics Market Outlook, By Services (2021-2030) ($MN)
  • Table 25 North America Cheminformatics Market Outlook, By Software (2021-2030) ($MN)
  • Table 26 North America Cheminformatics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 27 North America Cheminformatics Market Outlook, By Application (2021-2030) ($MN)
  • Table 28 North America Cheminformatics Market Outlook, By Chemical Analysis (2021-2030) ($MN)
  • Table 29 North America Cheminformatics Market Outlook, By Chemometrics (2021-2030) ($MN)
  • Table 30 North America Cheminformatics Market Outlook, By Chemical Databases (2021-2030) ($MN)
  • Table 31 North America Cheminformatics Market Outlook, By Molecular Modelling (2021-2030) ($MN)
  • Table 32 North America Cheminformatics Market Outlook, By Other Chemical Analysis (2021-2030) ($MN)
  • Table 33 North America Cheminformatics Market Outlook, By Virtual Screening (2021-2030) ($MN)
  • Table 34 North America Cheminformatics Market Outlook, By Drug Discovery and Validation (2021-2030) ($MN)
  • Table 35 North America Cheminformatics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 36 North America Cheminformatics Market Outlook, By End User (2021-2030) ($MN)
  • Table 37 North America Cheminformatics Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
  • Table 38 North America Cheminformatics Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
  • Table 39 North America Cheminformatics Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 40 North America Cheminformatics Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
  • Table 41 North America Cheminformatics Market Outlook, By Regulatory Compliance (2021-2030) ($MN)
  • Table 42 North America Cheminformatics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 43 Europe Cheminformatics Market Outlook, By Country (2021-2030) ($MN)
  • Table 44 Europe Cheminformatics Market Outlook, By Product (2021-2030) ($MN)
  • Table 45 Europe Cheminformatics Market Outlook, By Services (2021-2030) ($MN)
  • Table 46 Europe Cheminformatics Market Outlook, By Software (2021-2030) ($MN)
  • Table 47 Europe Cheminformatics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 48 Europe Cheminformatics Market Outlook, By Application (2021-2030) ($MN)
  • Table 49 Europe Cheminformatics Market Outlook, By Chemical Analysis (2021-2030) ($MN)
  • Table 50 Europe Cheminformatics Market Outlook, By Chemometrics (2021-2030) ($MN)
  • Table 51 Europe Cheminformatics Market Outlook, By Chemical Databases (2021-2030) ($MN)
  • Table 52 Europe Cheminformatics Market Outlook, By Molecular Modelling (2021-2030) ($MN)
  • Table 53 Europe Cheminformatics Market Outlook, By Other Chemical Analysis (2021-2030) ($MN)
  • Table 54 Europe Cheminformatics Market Outlook, By Virtual Screening (2021-2030) ($MN)
  • Table 55 Europe Cheminformatics Market Outlook, By Drug Discovery and Validation (2021-2030) ($MN)
  • Table 56 Europe Cheminformatics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 57 Europe Cheminformatics Market Outlook, By End User (2021-2030) ($MN)
  • Table 58 Europe Cheminformatics Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
  • Table 59 Europe Cheminformatics Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
  • Table 60 Europe Cheminformatics Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 61 Europe Cheminformatics Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
  • Table 62 Europe Cheminformatics Market Outlook, By Regulatory Compliance (2021-2030) ($MN)
  • Table 63 Europe Cheminformatics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 64 Asia Pacific Cheminformatics Market Outlook, By Country (2021-2030) ($MN)
  • Table 65 Asia Pacific Cheminformatics Market Outlook, By Product (2021-2030) ($MN)
  • Table 66 Asia Pacific Cheminformatics Market Outlook, By Services (2021-2030) ($MN)
  • Table 67 Asia Pacific Cheminformatics Market Outlook, By Software (2021-2030) ($MN)
  • Table 68 Asia Pacific Cheminformatics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 69 Asia Pacific Cheminformatics Market Outlook, By Application (2021-2030) ($MN)
  • Table 70 Asia Pacific Cheminformatics Market Outlook, By Chemical Analysis (2021-2030) ($MN)
  • Table 71 Asia Pacific Cheminformatics Market Outlook, By Chemometrics (2021-2030) ($MN)
  • Table 72 Asia Pacific Cheminformatics Market Outlook, By Chemical Databases (2021-2030) ($MN)
  • Table 73 Asia Pacific Cheminformatics Market Outlook, By Molecular Modelling (2021-2030) ($MN)
  • Table 74 Asia Pacific Cheminformatics Market Outlook, By Other Chemical Analysis (2021-2030) ($MN)
  • Table 75 Asia Pacific Cheminformatics Market Outlook, By Virtual Screening (2021-2030) ($MN)
  • Table 76 Asia Pacific Cheminformatics Market Outlook, By Drug Discovery and Validation (2021-2030) ($MN)
  • Table 77 Asia Pacific Cheminformatics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 78 Asia Pacific Cheminformatics Market Outlook, By End User (2021-2030) ($MN)
  • Table 79 Asia Pacific Cheminformatics Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
  • Table 80 Asia Pacific Cheminformatics Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
  • Table 81 Asia Pacific Cheminformatics Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 82 Asia Pacific Cheminformatics Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
  • Table 83 Asia Pacific Cheminformatics Market Outlook, By Regulatory Compliance (2021-2030) ($MN)
  • Table 84 Asia Pacific Cheminformatics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 85 South America Cheminformatics Market Outlook, By Country (2021-2030) ($MN)
  • Table 86 South America Cheminformatics Market Outlook, By Product (2021-2030) ($MN)
  • Table 87 South America Cheminformatics Market Outlook, By Services (2021-2030) ($MN)
  • Table 88 South America Cheminformatics Market Outlook, By Software (2021-2030) ($MN)
  • Table 89 South America Cheminformatics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 90 South America Cheminformatics Market Outlook, By Application (2021-2030) ($MN)
  • Table 91 South America Cheminformatics Market Outlook, By Chemical Analysis (2021-2030) ($MN)
  • Table 92 South America Cheminformatics Market Outlook, By Chemometrics (2021-2030) ($MN)
  • Table 93 South America Cheminformatics Market Outlook, By Chemical Databases (2021-2030) ($MN)
  • Table 94 South America Cheminformatics Market Outlook, By Molecular Modelling (2021-2030) ($MN)
  • Table 95 South America Cheminformatics Market Outlook, By Other Chemical Analysis (2021-2030) ($MN)
  • Table 96 South America Cheminformatics Market Outlook, By Virtual Screening (2021-2030) ($MN)
  • Table 97 South America Cheminformatics Market Outlook, By Drug Discovery and Validation (2021-2030) ($MN)
  • Table 98 South America Cheminformatics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 99 South America Cheminformatics Market Outlook, By End User (2021-2030) ($MN)
  • Table 100 South America Cheminformatics Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
  • Table 101 South America Cheminformatics Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
  • Table 102 South America Cheminformatics Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 103 South America Cheminformatics Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
  • Table 104 South America Cheminformatics Market Outlook, By Regulatory Compliance (2021-2030) ($MN)
  • Table 105 South America Cheminformatics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 106 Middle East & Africa Cheminformatics Market Outlook, By Country (2021-2030) ($MN)
  • Table 107 Middle East & Africa Cheminformatics Market Outlook, By Product (2021-2030) ($MN)
  • Table 108 Middle East & Africa Cheminformatics Market Outlook, By Services (2021-2030) ($MN)
  • Table 109 Middle East & Africa Cheminformatics Market Outlook, By Software (2021-2030) ($MN)
  • Table 110 Middle East & Africa Cheminformatics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 111 Middle East & Africa Cheminformatics Market Outlook, By Application (2021-2030) ($MN)
  • Table 112 Middle East & Africa Cheminformatics Market Outlook, By Chemical Analysis (2021-2030) ($MN)
  • Table 113 Middle East & Africa Cheminformatics Market Outlook, By Chemometrics (2021-2030) ($MN)
  • Table 114 Middle East & Africa Cheminformatics Market Outlook, By Chemical Databases (2021-2030) ($MN)
  • Table 115 Middle East & Africa Cheminformatics Market Outlook, By Molecular Modelling (2021-2030) ($MN)
  • Table 116 Middle East & Africa Cheminformatics Market Outlook, By Other Chemical Analysis (2021-2030) ($MN)
  • Table 117 Middle East & Africa Cheminformatics Market Outlook, By Virtual Screening (2021-2030) ($MN)
  • Table 118 Middle East & Africa Cheminformatics Market Outlook, By Drug Discovery and Validation (2021-2030) ($MN)
  • Table 119 Middle East & Africa Cheminformatics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 120 Middle East & Africa Cheminformatics Market Outlook, By End User (2021-2030) ($MN)
  • Table 121 Middle East & Africa Cheminformatics Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
  • Table 122 Middle East & Africa Cheminformatics Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
  • Table 123 Middle East & Africa Cheminformatics Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 124 Middle East & Africa Cheminformatics Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
  • Table 125 Middle East & Africa Cheminformatics Market Outlook, By Regulatory Compliance (2021-2030) ($MN)
  • Table 126 Middle East & Africa Cheminformatics Market Outlook, By Other End Users (2021-2030) ($MN)
目次
Product Code: SMRC24183

According to Stratistics MRC, the Global Cheminformatics Market is accounted for $3.4 billion in 2023 and is expected to reach $10.5 billion by 2030 growing at a CAGR of 17.5% during the forecast period. Chemoinformatics is the integration of computer and informational approaches to a variety of chemistry-related problems. Chemoinformatics is the blending of various information resources with the aim of converting data into knowledge and knowledge into information in order to make better decisions rapidly in the area of drug lead optimization. Pharmaceutical companies employ these methods when seeking for new drugs. These techniques can also be applied in a variety of other contexts in the chemical and related sectors.

According to the report published by Frontiers in Chemistry in April 2021, virtual screening strategies innovated the discovery of new bioactive molecules.

Market Dynamics:

Driver:

Increased drug development and discovery

The biotechnology and pharmaceutical sectors constantly strive to develop and market cutting-edge medications. Cheminformatics software and technologies are essential to this endeavor since they haveten the drug development process. With the assistance of these tools, researchers can quickly examine large data sets, model molecular interactions, and forecast the characteristics of possible drug candidates, greatly cutting down on the time and expense normally associated with trial-and-error methods. Additionally, cheminformatics helps chemists discover interesting medication candidates, comprehend the connections between the structure and activity of compounds, and improve the attributes of these molecules. As a result, the market for cheminformatics is expanding rapidly as businesses try to use these technologies to accelerate drug discovery, which will eventually result in the release of new drugs and therapies to deal with a variety of health issues.

Restraint:

High initial expenses

Implementing cheminformatics systems along with acquiring the required software, hardware, and knowledge can be expensive, especially for startups, academic institutions, and smaller research organizations with limited resources. For many potential users, the expense of licensing sophisticated cheminformatics software, purchasing potent computational resources, and training employees to utilize these tools effectively might operate as a barrier to entry. Additional ongoing costs for maintenance, updates, and support also add to the financial burden.

Opportunity:

Toxicology chemical informatics

Due to the vital role in ensuring the safety and efficacy of chemicals and pharmaceutical substances, chemical informatics for toxicology is a major driver of the cheminformatics market. Cheminformatics technologies are crucial for anticipating and assessing the potential toxicological effects of various chemical substances due to the growing demand for rigorous safety assessments and regulatory compliance. Moreover, with the aid of these technologies, scientists can model and simulate how chemicals interact with biological systems, assisting in the early identification of possible risks and their mitigation. This skill plays a crucial role in safeguarding public health as well as saving a significant amount of time and resources.

Threat:

Data security and privacy issues

Massive amounts of sensitive and confidential chemical and biological data, including details on prospective medicinal compounds, molecular structures, and research findings, are handled within this discipline. A top priority is to protect this data from unauthorized access, breaches, or theft, especially in the fiercely competitive chemical and pharmaceutical industries. However, these difficulties get worse due to legal restrictions, ethical considerations, and the need for researchers to follow strict data protection laws and address privacy and intellectual property issues. Data breaches or improper treatment can have serious repercussions, including legal consequences and reputational harm.

COVID-19 Impact:

The COVID-19 pandemic has had a wide range of effects on the market for cheminformatics. On the other hand, the need for rapid virus therapies and vaccinations pushed the use of cheminformatics techniques in drug development. These technologies were used by researchers to accelerate the medication development process and examine the molecular structure of the virus and its interactions with prospective therapeutic molecules. The need for chemical products and services increased as a result. The pandemic, however, caused difficulties for the cheminformatics sector. The general operations of the industry were impacted by supply chain disruptions, laboratory closures, and changes in research objectives.

The virtual screening segment is expected to be the largest during the forecast period

Virtual Screening segment hold the largest share over the projection period. Virtual screening is a method of computing that makes use of software and tools from the field of cheminformatics to forecast and examine the interactions between possible therapeutic molecules and certain biological targets, such as proteins or enzymes. It enables scientists to virtually evaluate a vast library of chemical compounds, reducing the number of potential therapeutic candidates for additional experimental testing. By minimizing the number of compounds that must be manufactured and analyzed in the lab, this method substantially speeds up the drug discovery pipeline while using less capital.

The software segment is expected to have the highest CAGR during the forecast period

Due to the wide variety of specialized software programs and tools developed to meet the requirements of researchers, chemists, and scientists in many sectors, the software segment is anticipated to have the highest CAGR throughout the projection period. Additionally, these software programs are made to handle and evaluate chemical and biological data, help with molecular modeling, forecast chemical properties, and speed up the creation of new drugs. Cheminformatics software includes tools for virtual screening, data visualization and analysis, chemical structure databases, and molecular modeling.

Region with largest share:

Due to growing financing in the biotechnology industry, North America held the majority of the market over the predicted period. It accelerates medication discovery, new platform releases and approvals, and the presence of numerous important firms in the area. For instance, Dotmatics introduced its small-molecule drug discovery service in the United States in July 2022. It is an integrated platform for scientific R&D that has expanded data management capabilities and workflows that are already set up. The Small Molecule Drug Discovery Solution minimizes operational inefficiencies, fosters increased research team efficiency, and hastens the conversion of data into insights and decisions.

Region with highest CAGR:

Asia Pacific is estimated to witness lucrative growth over the forecast period due to low manufacturing and labor costs and a supportive industrial environment, some developing economies in the Asia Pacific area, including India, China, and Singapore, have attracted major multinational firms to conduct research. Additionally, it is anticipated that the increasing rate of research activity in the rapidly developing countries of the Asia-Pacific area will support growth further.

Key players in the market

Some of the key players in Cheminformatics market include: Advanced Chemistry Development, Inc., Advent Informatics Pvt. Ltd., Agilent Technologies, Inc., Altoris, Bio-Rad Laboratories, Inc, BioSolveIT GmbH, Cambridgesoft Corp , Certara, Inc., ChemAxon Inc, Collaborative Drug Discovery Inc., Dassault Systems SE, Eidogen-Sertanty, Inc., Golden Helix, Inc., Kode Chemoinformatics, Modgraph Consultants Ltd., Molecular Discovery Ltd, Molinspiration Cheminformatics, Molsoft L.L.C, RTI International, Schrodinger, Inc. and Scilligence Corporation.

Key Developments:

In September 2022, Cadence Design Systems, Inc. completed the acquisition of OpenEye Scientific Software, Inc. Adding OpenEye's technologies and experienced team accelerates the Cadence Intelligent System Design strategy. It is done by extending Cadence's computational software core competency to molecular modeling and simulation targeted to life sciences.

In June 2022, TetraScience, the R&D Data Cloud, stated that ChemAxon, one of the leading web-based cheminformatics and bioinformatics software providers, joined the Tetra Partner Network. It is to help customers dramatically increase their capacity to find and synthesize chemical compounds with improved property profiles.

Products Covered:

  • Services
  • Software
  • Other Products

Applications Covered:

  • Chemical Analysis
  • Virtual Screening
  • Drug Discovery and Validation
  • Other Applications

End Users Covered:

  • Academic & Research Institutes
  • Biotechnology Companies
  • Contract Research Organizations
  • Pharmaceutical Companies
  • Regulatory Compliance
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Cheminformatics Market, By Product

  • 5.1 Introduction
  • 5.2 Services
  • 5.3 Software
  • 5.4 Other Products

6 Global Cheminformatics Market, By Application

  • 6.1 Introduction
  • 6.2 Chemical Analysis
    • 6.2.1 Chemometrics
    • 6.2.2 Chemical Databases
    • 6.2.3 Molecular Modelling
    • 6.2.4 Other Chemical Analysis
  • 6.3 Virtual Screening
  • 6.4 Drug Discovery and Validation
  • 6.5 Other Applications

7 Global Cheminformatics Market, By End User

  • 7.1 Introduction
  • 7.2 Academic & Research Institutes
  • 7.3 Biotechnology Companies
  • 7.4 Contract Research Organizations
  • 7.5 Pharmaceutical Companies
  • 7.6 Regulatory Compliance
  • 7.7 Other End Users

8 Global Cheminformatics Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Advanced Chemistry Development, Inc.
  • 10.2 Advent Informatics Pvt. Ltd.
  • 10.3 Agilent Technologies, Inc.
  • 10.4 Altoris
  • 10.5 Bio-Rad Laboratories, Inc
  • 10.6 BioSolveIT GmbH
  • 10.7 Cambridgesoft Corp
  • 10.8 Certara, Inc.
  • 10.9 ChemAxon Inc
  • 10.10 Collaborative Drug Discovery Inc.
  • 10.11 Dassault Systems SE
  • 10.12 Eidogen-Sertanty, Inc.
  • 10.13 Golden Helix, Inc.
  • 10.14 Kode Chemoinformatics
  • 10.15 Modgraph Consultants Ltd.
  • 10.16 Molecular Discovery Ltd
  • 10.17 Molinspiration Cheminformatics
  • 10.18 Molsoft L.L.C
  • 10.19 RTI International
  • 10.20 Schrodinger, Inc.
  • 10.21 Scilligence Corporation